Robert E. George - 07 Jun 2021 Form 4 Insider Report for Moleculin Biotech, Inc. (MBRX)

Role
Director
Signature
/s/ Jonathan Foster by Power of Attorney
Issuer symbol
MBRX
Transactions as of
07 Jun 2021
Net transactions value
$0
Form type
4
Filing time
09 Jun 2021, 16:25:01 UTC
Next filing
22 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MBRX Stock option (right to buy) Award +10,000 +60% 26,668 07 Jun 2021 Common Stock 10,000 $3.95 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.
F2 The options were issued in connection with the reporting person's Board of Director service to the Company.